Navigation Links
CytImmune in Medical Technology

CytImmune To Present At ASCO Phase I Clinical Trial of CYT-6091 to be Presented on June 3, 2007

...o 12 noon on June 3. Dr. Lawrence Tamarkin, CEO of cytimmune will present the poster abstract entitled "Prelimi...TNF nanomedicine. "Acceptance to ASCO provides cytimmune the opportunity to present its research to the lea...ology experts," said Dr. Lawrence Tamarkin, CEO of cytimmune Sciences. "For an emerging company, it's a chance ...

CytImmune Presents Positive CYT-6019 Data During the American Society of Clinical Oncology Annual Meeting in Chicago

... data of a National Cancer Institute conducted and cytimmune Sciences sponsored Phase 1 trial of CYT-6091 (Auri...vancing cancer therapy." In preclinical studies, cytimmune achieved safe and targeted delivery of TNF at leve...d the ASCO Poster Presentation can be found on the cytimmune website,
(Date:9/15/2014)... this week,s print issue of the journal Science ... from New Mexico, Montana and even the Netherlands, thanks ... and more the norm in these connected times. Yes, ... will produce innovations in biology, medicine, biotechnology and agriculture. ... scientist talked with that one, that one knew another ...
(Date:9/15/2014)... Sonja Schmid, an assistant professor in the Department of ... Liberal Arts and Human Sciences at Virginia Tech, has ... (CAREER) Award to study the prospects and problems of ... catastrophic failure of Japan,s Fukushima I Nuclear Power Plant ... the scientific community viewed nuclear emergencies, Schmid said. Three ...
Breaking Biology News(10 mins):Cells simply avoid chromosome confusion 2Cells simply avoid chromosome confusion 3Collaboration drives achievement in protein structure research 2'Nuclear disasters don't respect national boundaries' 2
Other Contents